Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Depreciation & Amortization - Total (2020 - 2025)

INVO Fertility (IVF) has disclosed Depreciation & Amortization - Total for 6 consecutive years, with $31391.0 as the latest value for Q3 2025.

  • On a quarterly basis, Depreciation & Amortization - Total fell 35.55% to $31391.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $120291.0, a 1.7% increase, with the full-year FY2024 number at $102103.0, up 27.11% from a year prior.
  • Depreciation & Amortization - Total was $31391.0 for Q3 2025 at INVO Fertility, roughly flat from $31378.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization - Total ranged from a high of $48705.0 in Q3 2024 to a low of $2431.0 in Q1 2021.
  • A 5-year average of $19420.1 and a median of $19705.0 in 2023 define the central range for Depreciation & Amortization - Total.
  • Peak YoY movement for Depreciation & Amortization - Total: soared 473.4% in 2022, then tumbled 35.55% in 2025.
  • INVO Fertility's Depreciation & Amortization - Total stood at $11432.0 in 2021, then skyrocketed by 70.47% to $19488.0 in 2022, then increased by 7.91% to $21029.0 in 2023, then soared by 30.46% to $27435.0 in 2024, then grew by 14.42% to $31391.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Depreciation & Amortization - Total are $31391.0 (Q3 2025), $31378.0 (Q2 2025), and $30087.0 (Q1 2025).